Zhejiang Jolly Pharmaceutical Co Ltd (300181) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Jolly Pharmaceutical Co Ltd (300181) has a cash flow conversion efficiency ratio of -0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-23.58 Million ≈ $-3.45 Million USD) by net assets (CN¥3.18 Billion ≈ $465.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Zhejiang Jolly Pharmaceutical Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.
Zhejiang Jolly Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Zhejiang Jolly Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Zhejiang Jolly Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Jolly Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Zhejiang Jolly Pharmaceutical Co Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sally Beauty Holdings Inc
NYSE:SBH
|
0.129x |
|
Tangshan Jidong Cement Co Ltd
SHE:000401
|
0.047x |
|
Nolato AB (publ)
ST:NOLA-B
|
0.038x |
|
TriMas Corporation
NASDAQ:TRS
|
0.095x |
|
North Long Dragon New Materials Technology Co. Ltd. A
SHE:301357
|
N/A |
|
Kumho Tire
KO:073240
|
0.080x |
|
Hyprop
JSE:HYP
|
0.039x |
|
Saha Pathana Inter-Holding PCL
BK:SPI
|
-0.003x |
Annual Cash Flow Conversion Efficiency for Zhejiang Jolly Pharmaceutical Co Ltd (2007–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Jolly Pharmaceutical Co Ltd from 2007 to 2025. View current stock price of Zhejiang Jolly Pharmaceutical Co Ltd for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥3.24 Billion ≈ $474.31 Million |
CN¥411.80 Million ≈ $60.26 Million |
0.127x | +20.59% |
| 2024-12-31 | CN¥2.82 Billion ≈ $412.57 Million |
CN¥297.05 Million ≈ $43.47 Million |
0.105x | +1.31% |
| 2023-12-31 | CN¥2.77 Billion ≈ $405.92 Million |
CN¥288.46 Million ≈ $42.21 Million |
0.104x | -9.91% |
| 2022-12-31 | CN¥2.76 Billion ≈ $403.86 Million |
CN¥318.59 Million ≈ $46.62 Million |
0.115x | -9.08% |
| 2021-12-31 | CN¥1.98 Billion ≈ $290.21 Million |
CN¥251.80 Million ≈ $36.85 Million |
0.127x | -21.95% |
| 2020-12-31 | CN¥1.72 Billion ≈ $251.61 Million |
CN¥279.69 Million ≈ $40.93 Million |
0.163x | +77.59% |
| 2019-12-31 | CN¥1.41 Billion ≈ $206.00 Million |
CN¥128.94 Million ≈ $18.87 Million |
0.092x | +62.31% |
| 2018-12-31 | CN¥1.39 Billion ≈ $203.01 Million |
CN¥78.28 Million ≈ $11.46 Million |
0.056x | +1192.59% |
| 2017-12-31 | CN¥1.49 Billion ≈ $218.09 Million |
CN¥6.51 Million ≈ $952.09K |
0.004x | -88.98% |
| 2016-12-31 | CN¥1.47 Billion ≈ $215.38 Million |
CN¥58.30 Million ≈ $8.53 Million |
0.040x | -41.45% |
| 2015-12-31 | CN¥1.44 Billion ≈ $210.07 Million |
CN¥97.13 Million ≈ $14.21 Million |
0.068x | +330.67% |
| 2014-12-31 | CN¥871.76 Million ≈ $127.57 Million |
CN¥13.70 Million ≈ $2.00 Million |
0.016x | -58.87% |
| 2013-12-31 | CN¥772.52 Million ≈ $113.04 Million |
CN¥29.50 Million ≈ $4.32 Million |
0.038x | -11.63% |
| 2012-12-31 | CN¥705.92 Million ≈ $103.30 Million |
CN¥30.51 Million ≈ $4.46 Million |
0.043x | +116.47% |
| 2011-12-31 | CN¥683.92 Million ≈ $100.08 Million |
CN¥13.65 Million ≈ $2.00 Million |
0.020x | -93.61% |
| 2010-12-31 | CN¥207.17 Million ≈ $30.32 Million |
CN¥64.78 Million ≈ $9.48 Million |
0.313x | +18.04% |
| 2009-12-31 | CN¥165.70 Million ≈ $24.25 Million |
CN¥43.89 Million ≈ $6.42 Million |
0.265x | +26.77% |
| 2008-12-31 | CN¥149.11 Million ≈ $21.82 Million |
CN¥31.16 Million ≈ $4.56 Million |
0.209x | +88.11% |
| 2007-12-31 | CN¥144.47 Million ≈ $21.14 Million |
CN¥16.05 Million ≈ $2.35 Million |
0.111x | -- |
About Zhejiang Jolly Pharmaceutical Co Ltd
Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People's Republic of China and internationally. It offers Wuling capsule to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kid… Read more